Produktinformation
- sodium;(5R,6Z)-6-(6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-3-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate;hydrate
Applications BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.
References Maiti, S., et al.: Curr. Med. Chem., 5, 441 (1998), Barnaud, G., et al.: Antimicrob. Agents Chemother., 48, 1040 (2004), Szabo, D., et al.: J. Clin. Microbiol., 43, 5058 (2005),